The invention relates to compounds of the formula I
wherein the variables are as defined in the claims. The compounds are A
2A
-receptor ligands, such as antagonists, agonists, reverse agonists or partial agonists, and are useful in the treatment of neurological and psychiatric disorders where an A
2A
-receptor is implicated.
本发明涉及公式I的化合物,其中变量如权利要求所定义。该化合物是A2A受体
配体,如拮抗剂,激动剂,反向激动剂或部分激动剂,并且在治疗涉及A2A受体的神经和精神障碍方面有用。